Henry Y Li is a notable inventor based in Visalia, CA (US), recognized for his contributions to the field of biomedical engineering. He holds a total of 5 patents, showcasing his innovative approach to developing advanced diagnostic and treatment agents.

Latest Patents

One of his latest patents involves targeted polymerized liposome diagnostic and treatment agents. These polymerized liposome particles are linked to a targeting agent and may also be associated with a contrast enhancement agent. They can encapsulate treatment agents, such as proteins, drugs, or hormones, allowing for directed delivery to specific biological sites. This technology enables in vitro and in vivo studies through various imaging techniques, including magnetic resonance, radioactive, x-ray, or optical imaging. The targeted polymerized liposome particles interact with biological targets, enhancing the imaging of molecules in cells and tissues during disease and pathology.

Career Highlights

Throughout his career, Henry Y Li has worked with Targesome, Inc., where he has made significant advancements in his field. His innovative work has contributed to the development of technologies that improve diagnostic and therapeutic outcomes in medicine.

Collaborations

Henry has collaborated with notable individuals such as King Chuen Li and Mark David Bednarski, further enhancing the impact of his work in the biomedical sector.

Conclusion

Henry Y Li's innovative contributions to targeted polymerized liposome technology demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of biological interactions and the potential for improved treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com